Celecoxib for the treatment of non muscle invasive bladder cancer. Results from the first phase II clinical trial

被引：1
|
作者：
Pagliarulo, V. [1 ]
Martines, I. [1 ]
Telari, S. [1 ]
Ancona, P. [1 ]
Trerotoli, P. [2 ]
Albo, G. [1 ]
Pagliarulo, A. [1 ]
机构：
[1] Univ Bari, Sezione Urol, DETO, I-70121 Bari, Italy
[2] Univ Bari, Dipartimento Med Interna & Med Publ, I-70121 Bari, Italy
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2008年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1569-9056(08)60909-4
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
912
引用
收藏
页码：299 / 299
页数：1
相关论文
共 50 条
  • [21] MULTIMODAL BLADDER PRESERVATION TECHNIQUE FOR MUSCLE INVASIVE BLADDER CANCER: RESULTS FROM A PROSPECTIVE TRIAL
    Inamoto, Teruo
    Takahara, Kiyoshi
    Ibuki, Naokazu
    Takai, Tomoaki
    Uchimoto, Taizo
    Saito, Kenkichi
    Tanda, Naoki
    Yoshikawa, Yuki
    Minami, Koichiro
    Hirano, Hajime
    Nomi, Hayahito
    Azuma, Haruhito
    Yamamoto, Kiyohito
    Shinbo, Taijyu
    Yamamoto, Kazuhiro
    Narumi, Yoshifumi
    JOURNAL OF UROLOGY, 2017, 197 (04): : E249 - E249
  • [22] Phase I trial of hypofractionated radiotherapy and pembrolizumab in the treatment of muscle invasive/metastatic bladder cancer: Results of the PLUMMB trial.
    Huddart, Robert A.
    Hafeez, Shaista
    Nuzzaci, Emilia
    Jones, Kelly
    Tree, Alison
    Greenlay, Emily
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [23] Optimizing Clinical Trial Design for Patients with Non-muscle-invasive Bladder Cancer
    Weinstock, Chana
    Agrawal, Sundeep
    Chang, Elaine
    EUROPEAN UROLOGY, 2022, 82 (01) : 47 - 48
  • [24] The effect of a neoadjuvant instillation of chemotherapy in the prevention of recurrences of non-muscle invasive bladder cancer. Preliminary results of the PRECAVE prospective, controlled, randomized clinical trial
    Carrion, Monsalve D. M.
    Gomez, Rivas J.
    Trelles, C. R.
    Ballesteros, Ruiz C.
    Alvarez-Maestro, M.
    Aguilera, Bazan A.
    Martinez-Pineiro, L.
    EUROPEAN UROLOGY, 2021, 79 : S1043 - S1044
  • [25] Phase II study of concurrent chemoradiotherapy (CCRth) for bladder preservation in the treatment of muscle invasive bladder cancer
    El Taher, A. Mohamed
    Mekawy, M.
    Eid, S. Shehata
    Mostafa, H. G. El Din
    Aziz, A. M. Abdel
    Kamel, Y. Mostafa
    EJC SUPPLEMENTS, 2007, 5 (04): : 310 - 310
  • [26] Repeat transurethral resection of the bladder and the results of treatment in patients with non-muscle invasive bladder cancer
    Semenov, A. V.
    Kosulina, A. A.
    ONKOUROLOGIYA, 2011, 7 (04): : 37 - 41
  • [27] A Phase II Trial of Neoadjuvant Erlotinib in Patients With Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy: Clinical and Pathological Results Editorial Comment
    Wood, David P.
    JOURNAL OF UROLOGY, 2011, 185 (03): : 811 - 812
  • [28] A phase II, single arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with metastatic bladder cancer.
    Chatterjee, Aradeep
    Bhattacharya, Sudin
    Chatterjee, Ashim Kumar
    Chakraborty, Amitava
    Bhakta, Radhe S.
    Biswas, Jaydip
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [29] Phase I/II trial of cetuximab with 5-fluorouracil and mitomycin C concurrent with radiotherapy in patients with muscle invasive bladder cancer.
    Hussain, Syed A.
    Buckley, Laura
    Kaur, Baljit
    Hendron, Carey
    Zarkar, Anjali
    Ford, Daniel
    Viney, Richard
    Syndikus, Isabel
    Malik, Zafar
    Eswar, Chinnamani
    Desai, Amisha
    Southgate, Elizabeth
    Mangar, Stephen
    Van Der Voet, Johannes
    Lydon, Anna
    James, Nicholas D.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] TUXEDO: a phase I/II trial of cetuximab with chemoradiotherapy in muscle-invasive bladder cancer
    James, Nicholas D.
    Liu, Wenyu
    Pirrie, Sarah
    Kaur, Baljit
    Hendron, Carey
    Ford, Daniel
    Zarkar, Anjali
    Viney, Richard
    Southgate, Elizabeth
    Desai, Amisha
    Hussain, Syed A.
    BJU INTERNATIONAL, 2023, 131 (01) : 63 - 72
12345